期刊文献+

胱抑素C在早期糖尿病肾病诊断中的应用 被引量:1

The Elf Inhibition C in the Diagnosis of Early Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨血清胱抑素C在早期糖尿病肾病诊断中的意义。方法选取2型糖尿病患者156例,依据尿白蛋白/肌酐比值(ACR)分为3组,检测血肌酐(Scr)、尿素氮(BUN)、尿微量白蛋白/肌酐比值(ACR)、胱抑素C。采用酶法检测Scr、BUN;免疫透射比浊法测定ACR;颗粒增强透射免疫比浊法检测胱抑素C。采用C-G公式计算肾小球滤过率(GFR)。结果早期糖尿病肾病组与单纯糖尿病比较显示血清胱抑素C水平升高(P<0.05);临床糖尿病肾病组血清胱抑素C、Scr、GFR水平与单纯糖尿病肾病组、早期糖尿病肾病组相比有显著性差异(P<0.05)。结论血清胱抑素C是预测早期糖尿病肾病的敏感指标。 Objective To investigate the significance of urinary inhibition C serum in the diagnosis of diabetic ne- phropathy. Methods According to urinary albumin/creatinine ratio (ACR), choose 156 patients with type 2 diabetes, and divided them into three groups to detect serum creatinine (Scr), urea nitrogen (BUN), urine trace albumin/creatinine ratio (ACR), urinary inhibition C. Using enzymatic detection of Scr, BUN, Immune transmission turbidimetry determination of ACR; Particles reinforced transmission immune turbidimetric method to detect urinary inhibition C. The C- G formula Glomerular filtration rate (GFR) is calculated by the C-G formula. Results Early diabetic nephropathy group compared with pure diabetes showed that urinary inhibition C levels of serum rises (P 〈 0.05); There are significant difference on clin- ical diabetic nephropathy group (serum inhibition C, Scr, GFR level and simple diabetic nephropathy group, the early dia- betic nephropathy group compared statistically significant (P 〈 0.05). Conclusion Serum (inhibition C is a sensitive in- dex of predictor of diabetic nephropathy.
作者 刘昌盛
机构地区 莒南县人民医院
出处 《菏泽医学专科学校学报》 2014年第3期36-37,45,共3页 Journal of Heze Medical College
关键词 糖尿病 并发症 肾病 病因学 2型糖尿病 胱抑素C diabetes/complications kidney diseases/etiology type 2 diabetes the elf inhibition C
  • 相关文献

参考文献6

  • 1中国2型糖尿病防治指南制定委员会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2010.
  • 2Levey AS, Coresh J, Balk E, et al.National Kidney Foundation pratice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Ann Intern Med,2003,139:137-147.
  • 3I Aksun SA,Ozmen D,Ozmen B,et al.Beta2-microglobulin and cystatin C intype 2 diabetes:assessment of diabetic nephropathy[J].Exp Clin Endocrinol Diabetes,2004,112:195-200.
  • 4傅美华,陈军,陈秋.胱抑素C与糖尿病肾病的相关研究进展[J].中国全科医学,2013,16(2):229-231. 被引量:64
  • 5Jeon YK, Kim MR, Huh JE, et al.Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J].J Korean Med Sei, 2011,26(2) 258-263.
  • 6Pucci L, Triscomia S, Lucchesi D, et al.Cystatin C and estimates of renal function:searching for a better measure of kidney function in diabetic patients[J].Clinical Chemistry,2007,53(3):480-488.

二级参考文献27

  • 1Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,(12):1090-1101.
  • 2中国2型糖尿病防治指南制定委员会.中国2型糖尿病防治指南[M]北京:北京大学医学出版社,2010.
  • 3Macisaac RJ,Premaratne E,Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C[J].Clinical Microbiology Reviews,2011,(02):61-67.
  • 4Yang YS,Peng CH,Lin CK. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes[J].Internal Medicine,2007,(12):801-806.doi:10.2169/internalmedicine.46.6081.
  • 5Zhang PP,Zhan JF,Xie HL. Evaluation of glomerular filtration rate using cystatin C in diabetic patients analysed by multiple factors including tubular function[J].Journal of International Medical Research,2010,(02):473-483.
  • 6Grubb A,Bjrk J,Nyman U. Cystatin C,a marker for successful aging and glomerular filtration rate,is not influenced by inflammation[J].Scandinavian Journal of Clinical and Laboratory Investigation,2011,(02):145-149.
  • 7Jeon YK,Kim MR,Huh JE. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J].Journal of Korean Medical Science,2011,(02):258-263.
  • 8Sahakyan K,Lee KE,Shankar A. Serum cystatin C and the incidence of type 2 diabetes mellitus[J].Diabetologia,2011,(06):1335-1340.
  • 9Pucci L,Triscornia S,Lucchesi D. Cystatin C and estimates of renal function:searching for a better measure of kidney function in diabetic patients[J].Clinical Chemistry,2007,(03):480-488.doi:10.1373/clinchem.2006.076042.
  • 10Hojs R,Bevc S,Ekart R. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function[J].Nephrology Dialysis Transplantation,2006,(07):1855-1862.

共引文献65

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部